Psychopharmacologic management of opioid-dependent women during pregnancy

Peter R. Martin, Amelia M. Arria, Gabriele Fischer, Karol Kaltenbach, Sarah H. Heil, Susan M. Stine, Mara G. Coyle, Peter Selby, Hendree E. Jones

Research output: Contribution to journalArticle

Abstract

Illicit drug use during pregnancy presents complex clinical challenges, including reducing drug use and treating psychiatric disorders. Pharmacologic treatment of psychiatric disorders in a pregnant woman requires an evaluation of the balance between potential clinical benefit and the risk of potential neonatal consequences. This study describes psychiatric symptoms in 111 opioid-dependent pregnant women and their prescribed psychotropic medications. Hypomania, generalized anxiety disorder and depression were the most common disorders for which psychiatric symptoms were endorsed. Over half of women studied were prescribed some form of psychoactive medication during pregnancy. Pharmacologic vs. non-pharmacologic treatment approaches in this patient population are discussed.

Original languageEnglish (US)
Pages (from-to)148-156
Number of pages9
JournalAmerican Journal on Addictions
Volume18
Issue number2
DOIs
StatePublished - Mar 2009

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Psychopharmacologic management of opioid-dependent women during pregnancy'. Together they form a unique fingerprint.

  • Cite this

    Martin, P. R., Arria, A. M., Fischer, G., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Selby, P., & Jones, H. E. (2009). Psychopharmacologic management of opioid-dependent women during pregnancy. American Journal on Addictions, 18(2), 148-156. https://doi.org/10.1080/10550490902772975